Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr 29;3(3):e12730.
doi: 10.1002/emp2.12730. eCollection 2022 Jun.

Acute aortic occlusion associated with COVID-19: A rare complication of a not so rare disease

Affiliations
Case Reports

Acute aortic occlusion associated with COVID-19: A rare complication of a not so rare disease

Ryan Lee et al. J Am Coll Emerg Physicians Open. .

Abstract

Recent literature has reported a high prevalence of thrombotic events associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for causing coronavirus disease 2019 (COVID-19) infection. Although venous thromboembolism complications have been well studied, arterial thrombosis is less well described. Our aim is to describe acute aortoiliac occlusion (AAO), itself a rare condition, as a complication of COVID-19 infection and review existing literature regarding its presentation and available treatment modalities. Over a 2-week span in late 2021, 2 patients with recent COVID-19 infection presented to our tertiary care hospital with AAO. Each case was treated with a multimodal therapeutic approach, including vascular interventional radiology guided thrombolysis, vascular surgical approach, and systemic anticoagulation. Although two separate primary approaches were taken, each resulted in high morbidity and death in both cases. Acute aortic occlusion is a rare disease associated with high morbidity and mortality. COVID-19 has further been associated with arterial thromboembolic complications, including AAO, as presented here. More research is needed to identify patients at highest risk of developing arterial thromboembolic disease after COVID-19 infection as well as to determine ideal therapeutic options in order to improve the exceedingly high morbidity and mortality associated with this complication.

Keywords: COVID‐19; acute aortic occlusion; anticoagulation; hypercoagulable; thromboembolism.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Physical examination findings of patient presented in Case 1 with acute aortic occlusion as a result of COVID‐19 infection
FIGURE 2
FIGURE 2
Computed tomography angiography (CTA) imaging revealing infrarenal aortic occlusion with extension into the bilateral common iliac arteries
FIGURE 3
FIGURE 3
Computed tomography angiography (CTA) imaging revealing near occlusive filling defect of the infrarenal aorta seen in Case 2

References

    1. Mansory EM, Srigunapalan S, Lazo‐Langner A. Venous thromboembolism in hospitalized critical and noncritical COVID‐19 patients: a systematic review and meta‐analysis. TH Open. 2021;5(3):e286‐e294. Published 2021 Jul 6. 10.1055/s-0041-1730967 - DOI - PMC - PubMed
    1. Wu C, Liu Y, Cai X, Zhang W, Li Y, Fu C. Prevalence of venous thromboembolism in critically Ill patients with coronavirus disease 2019: a meta‐analysis. Front Med (Lausanne). 2021;8:603558. Published 2021 Apr 29. 10.3389/fmed.2021.603558 - DOI - PMC - PubMed
    1. Kollias A, Kyriakoulis KG, Lagou S, Kontopantelis E, Stergiou GS, Syrigos K. Venous thromboembolism in COVID‐19: a systematic review and meta‐analysis. Vasc Med. 2021;26(4):415‐425. 10.1177/1358863X21995566 - DOI - PMC - PubMed
    1. Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID‐19. J Thromb Haemost. 2020;18(8):1995‐2002. 10.1111/jth.14888 - DOI - PMC - PubMed
    1. Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID‐19 is high and associated with a higher risk of mortality: a systematic review and meta‐analysis. E Clin Med. 2020;29:100639. 10.1016/j.eclinm.2020.100639 - DOI - PMC - PubMed

Publication types